Treatment results in remission for about 85% of patients with antineutrophil cytoplasmic antibody (ANCA)-associated small-vessel vasculitis; however, 11–57% of these suffer relapse, which can ...

Bosch and colleagues searched MEDLINE for studies published in English between 1966 and 2007 that evaluated the available treatments for antineutrophil cytoplasmic antibody (ANCA)-associated ...

Neutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, ...

Neutrophils, one of the immune system warriors that were thought to be all the same, turn out to be diverse. Unfortunately, these cells ...

Alaska Native and American Indian adults have a high prevalence of AAV, with distinct clinical characteristics and treatment patterns observed.

Reducing glucocorticoid use in the treatment of giant cell arteritis ... Nearly all children with ANCA-associated vasculitis demonstrate active kidney disease at diagnosis, and their renal ...

Rituximab may be an effective therapeutic option in the management of severe necrotizing scleritis associated with AAV.

Birmingham Vasculitis Activity Scores (BVAS) were used to identify disease manifestations. Key efficacy outcomes included remission at week 26, sustained remission at week 52, relapse rates, the ...

Researchers found that use of immunosuppressive medication was a strong protective factor, associated with a 60% reduction in ...

Long-term use of propylthiouracil (PTU) may precipitate antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) complicated by hemophagocytic activity, according to a case report ...

The general principles guiding the treatment of vasculitis are to induce and maintain ... TA appears to be associated with an increased incidence of intrauterine growth retardation (26% of patients).